clinical trial · NCT05820451
Impella Real-World Surveillance of Patients Using Sodium Bicarbonate
Abiomed Inc.·—·completed·n = 312
Cardiogenic ShockHigh Risk PCIImpella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solutionImpella RP with Sodium Bicarbonate used as purge solution
brief summary
The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.
started
Dec 15, 2022
primary completion
Feb 22, 2024
completion
Feb 22, 2024
last updated
Sep 4, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol